Sign up to save your podcasts
Or
Share MDT perspectives on the current and emerging second-line treatment options for SCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MDT perspectives on the current and emerging second-line treatment options for SCLC
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting
The multidisciplinary team:
- Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
View all episodes
By touchpodcasttouchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting
The multidisciplinary team:
- Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/